Optinose - OPTN Sotuvning sof marjinal rentabelligi

Optinose - OPTN emitenti grafik logotipi

XHANCE ning rinosinuzitni davolashdagi tijorat qamrovining kengayishi impulsni oshirmoqda, bunda sof foyda marjasi OptiNose, Inc. (OPTN) biznesining haqiqiy rentabelligini aks ettiradi. EDS tizimi va XHANCE qurilmasi dori vositasining sinuslarga chuqur kirishini ta'minlaydi, anti-polip agentlari bilan integratsiya esa LOR terapiyasi uchun standartni belgilaydi. -36.60 qiymati joriy ko'rsatkichni ifodalaydi, bu esa barqaror daromadlilik tendentsiyasi va tasodifiy sakrashlar o'rtasidagi farqni aniqlash imkonini beradi.

OptiNose, Inc. (OPTN) Sotuvning sof rentabelligi: 04.07.2022 - 31.05.2025 davri uchun

Optinose (OPTN) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning har tomonlama tahlili:OptiNose, OPTN
OptiNose Inc ishlab chiqargan mahsulot

Barqaror aktivlarni aniqlash uzoq muddatli tendentsiyalarni bozor shovqinlaridan ajratishni talab qiladi. Sof foyda marjasi barcha xarajatlardan keyin har bir dollar daromadidan qolgan foyda qismini o'lchaydi. OptiNose, Inc. (OPTN) uchun ushbu hisob-kitob rinosinuzit davolashga bo'lgan talab ortib borayotgan bir paytda dori yetkazib berish tizimlarini tijoratlashtirish samaradorligini ko'rsatadi. Sof foyda marjasidagi ijobiy dinamika biznes modelining kengaytiriluvchanligini tasdiqlaydi. Investorlar emitentning operatsion barqarorligini baholash uchun ushbu grafikdan foydalanishlari lozim.

OptiNose, Inc. kimlar bilan raqobatlashadi

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sof marja Ligand (LGND)|Sotuvning sof marjinal rentabelligi amneal.com (AMRX)|Sotuvning sof marjinal rentabelligi PRGO (perrigo.com)|Alvotech SA (ALVO) - Sof marja|Liquidia Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Sof marja|Sotuvning sof rentabelligi MNKD|Sof marja Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi SPRY|TBPH - Sof marja|Aquestive Pharma - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi scpharmaceuticals.com SCPH|Tectonic - Sotuvning sof marjinal rentabelligi|TNXP - Sotuvning sof marjinal rentabelligi|SXTC: Sotuvning sof marjinal rentabelligi|Eupraxia Pharma - Sof foyda normasi|BHST (bioharvest.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi EXOZ (invizyne.com)|Sotuvning sof marjinal rentabelligi ORMP|Kompaniya sotuv marjasi Entera Bio|Sotuvning sof marjinal rentabelligi HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Sof marja|Cumberland Corp - Sotuvning sof marjinal rentabelligi|QNTM - Sotuvning sof marjinal rentabelligi|FibroGen, Inc. (FGEN) - Sof marja|TELO: Kompaniyaning sof rentabelligi|RANI (Rani Therapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sof marja synergychc.com SNYR|Sof marja Rallybio Corp. (RLYB)|LEXX - Sof marja|Sotuvning sof marjinal rentabelligi PULM (pulmatrix.com)|Kompaniyaning sof rentabelligi PTHL (Pheton)|APM - Sof marja|Kompaniya sotuv marjasi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Sof marja|TNF Pharma (TNFA) - Sotuvning sof marjinal rentabelligi|YCBD (cbdmd.com) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi PainReform (PRFX)|Sof marja Altamira Therapeutics (CYTO)|Kompaniya sotuv marjasi Lipella Pharma|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma